Abstract
Purpose: The aim of this study was to evaluate the cytotoxic, phototoxic, genotoxic and photogenotoxic potential of gemifloxacin mesylate (GFM), its main synthetic impurity (SI) and one isolated and structurally elucidated degradation product (DP). Methods: The neutral red uptake (NRU) and reduction of 2,5-diphenyl-3,-(4,5-dimethyl-2-thiazolyl)tetrazolium bromide (MTT) assays were performed as in vitro endpoints to evaluate cytotoxicity and phototoxicity in a 3T3 cell line, and predict toxicity and/or phototoxicity after systemic administration of the drug. The in vitro alkaline single-cell electrophoresis (comet) assay was used to evaluate the genotoxic and photogenotoxic potential of the substances using the same cell line. Results: The results showed that the SI and the DP are more cytotoxic and phototoxic than the drug GFM using the 3T3 cell line. In the comet assay, the drug GFM was found to be more genotoxic and photogenotoxic than its related substances. Conclusions: Our findings highlight the relevance of the biological safety studies to increase the knowledge regarding the toxic potential of the related substances, which can be associated with the drug side effects and toxicity.
Similar content being viewed by others
References
FDA. Food and Drug Administration. Information prescribing. 2010 January 15. Available from: http://www.fda.gov/medwatch/safety/2007/May_PI/Factive_PI.pdf.
A. Anzueto, M. Miravitlles, Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD, Respir. Med., 2010, 104, 1396–1403.
R. Stahlmann, Clinical Toxicological aspects of quinolones, Toxicol. Lett., 2002, 127, 269–277.
A. Albini, S. Monti, Photophysics and photochemistry of fluoroquinolones, Chem. Soc. Rev., 2003, 32, 238–250.
R. S. Dawe, S. H. Ibbotson, J. B. Sanderson, E. M. Thomson, J. Fergunson, A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity, Br. J. Dermatol., 2003, 149, 1232–1241.
K. Yabe, K. Goto, T. Jindo, M. Sekiguchi, K. Furuhama, Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation, Toxicol. Lett., 2005, 157, 203–210.
S. Albertini, A. A. Chetelat, B. Miller, W. Muster, E. Pujadas, R. Strobel, E. Gocke, Genotoxicity of 17-gyrase and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems, Mutagenesis, 1995, 10, 343–351.
R. D. Snyder, C. S. Cooper, Photogenotoxicity of fluoroquinolones in Chinese hamster V79 cells: dependency on active topoisomerase II, Photochem. Photobiol., 1999, 69, 288–293.
A. C. Singh, M. Kumar, A. M. Jha, Genototoxicity of lomefloxacin–an antibacterial drug in somatic and germ cells of Swiss albino mice in vivo, Mutat. Res., 2003, 535, 35–42.
T. Itoh, K. Mitsumori, S. Kawaguchi, Y. F. Sasaki, Genotoxic potential of quinolone antimcrobials in the in vitro comet assay and micronucleus test, Mutat. Res., 2006, 603, 135–144.
C. S. Paim, F. Führ, A. B. Barth, C. E. Gonçalves, N. Nardi, M. Steppe, E. E. S. Schapoval, Gemifloxacin mesylate (GFM) stability evaluation applying a validated bioassay method and in vitro cytotoxic study, Talanta, 2011, 83, 1774–1779.
D. Jacobson-Kram, T. McGovern, Toxicological overview of impurities in pharmaceutical products, Adv. Drug Delivery Rev., 2007, 59, 38–42.
ICH. Harmonised Tripartite Guideline: Impurities in New Drug Substances–Q3A(R2), Commission of the European Communities, Geneva, 2006, pp. 1–15.
OECD Guidelines for the Testing of Chemicals: Test Guideline 432. In vitro 3T3 NRU Phototoxicxity test, OECD Publication Office, Paris, 2004.
E. Borenfreund, J. A. Puerner, Toxicity determined in vitro by morphological alterations and neutral red absorption, Toxicol. Lett., 1985, 24, 119–124.
T. Mosmann, Rapid colorimetric assay to cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 1983, 5, (1/2) 55–63.
V. Ugartondo, M. Mitjans, C. Lozano, J. L. Torres, M. P. Vinardell, Comparative study of the cytotoxicity induced by antioxidant epicatechin conjugates obtained from grape, J. Agric. Food Chem., 2006, 54, 6945–6950.
N. P. Singh, M. T. McCoy, E. L. Tice, E. L. Schneider, A simple technique for quantitation of low levels of DNA damage in individual cells, Exp. Cell Res., 1998, 75, 184–191.
V. Martinez, E. Corsini, M. Mitjans, A. Pinazo, M. P. Vinardell, Evaluation of eye and skin irritation of arginine-derivative surfactants using different in vitro endpoints as alternatives to the in vivo assays, Toxicol. Lett., 2006, 164, 259–267.
G. Fotakis, J. A. Timbrell, In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride, Toxicol. Lett., 2006, 160, 171–177.
M. Struwe, K. O. Greulich, W. Suter, U. Plappert-Helbig, The photo comet assay–a fast screening assay for the determination of photogenotoxicity in vitro, Mutat. Res., 2007, 632, 44–57.
C. S. Paim, F. Führ, D. S. Miron, R. Pereira, M. D. Malesuik, M. Steppe, E. E. S. Schapoval, Stability-indicating LC assay and determination of system suitability limits with a robustness test of gemifloxacin mesylate in tablets, Curr. Anal. Chem., 2010, 6, 269–276.
G. Repetto, A. Peso, J. L. Zurita, Neutral red uptake assay for the estimation of cell viability/cytotoxicity, Nat. Protoc., 2008, 3, 1125–1131.
Y. Liu, D. A. Peterson, H. Kimura, D. Schubert, Mechanism of cellular 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, J. Neurochem., 1997, 69, 581–593.
M. V. Berridge, P. M. Herst, A. S. Tan, Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction, Biotechnol. Annu. Rev., 2005, 11, 127–152.
A. M. Lynch, P. J. Guzzieb, D. Baurer, E. Gocke, S. Itoh, A. Jacobs, C. A. M. Krul, A. Schepky, N. Tanaka, P. Kasper, Considerations on photochemical genotoxicity. II: report of the 2009 International Workshop on Genotoxicity Testing Working Group, Mutat. Res., 2011, 723, 91–100.
FDA/CDER Guidance for Industry: Photosafety Testing, 2003.
EMEA. European Medicines Agency. ICH Topic S 2 B. Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals. Step 5. CPMP/ICH/174/95, March 1998.
S. Brendler-Schwaab, A. Czich, B. Epe, E. Gocke, B. Kaina, L. Müller, D. Pollet, D. Utesch, Photochemical genotoxicity: principles and test methods Report of a GUM task force, Mutat. Res., 2004, 566, 65–91.
S. Onoue, Y. Tsuda, Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances, Pharm. Res., 2006, 23, 156–164.
S. Onoue, M. Ochi, G. Gandy, Y. Seto, N. Igarashi, Y. Yamauchi, S. Yamada, High-throughput screening system for identifying phototoxic potential of drugs candidates based on derivatives of reactive oxygen metabolites, Pharm. Res., 2010, 27, 1610–1619.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paim, C.S., Nogueira, D.R., Mitjans, M. et al. Biological safety studies of gemifloxacin mesylate and related substances. Photochem Photobiol Sci 12, 805–812 (2013). https://doi.org/10.1039/c3pp25369d
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c3pp25369d